Molecular diagnostics refers to the tests conducted to detect proteins or nucleic acids at the molecular level. In the in-vitro diagnostics industry, molecular diagnostics has emerges as one of the biggest segments. It has been witnessing tremendous growth over the last two decade since the introduction of PCR tests for Chlamydia trachomatis (CT), Neisseria gonorrhea (NG) and HIV.
The molecular diagnostic tests uses a number of technologies such as polymerase chain reaction, hybridization (ISH AND FISH), mass spectrometry, transcription mediated amplification (TMA), next generation sequencing, biochips and microfluidics, others which includes nanotechnology and proteomics. The polymerase chain reaction dominated the molecular diagnostics market in Europe accounting for the share of 40.1% in 2014 as the technique is cost-effective way for copying or amplification of small segments of DNA or RNA.
Get PDF Brochure for more Professional and Technical industry insights: http://bit.ly/2cQyDGh
In Europe, the market for molecular diagnostics is experiencing significant growth on account of the increasing incidence of infectious diseases. The growing adoption of customized medicines and companion diagnostics is also boosting this market substantially in this region, notes the study.
The report studies the Europe molecular diagnostics market on the basis of the technology utilized, application, and the region. Polymerase chain reaction (PCR), mass spectrometry, hybridization (ISH and FISH), transcription Mediated Amplification (TMA), biochips and microfluidics, next-generation sequencing, and nanotechnology and proteomic have been identified as the main molecular diagnostic technologies in this study.
Geographically, the Europe market for molecular diagnostics has been segmented into Northern Europe, Southern Europe, Eastern Europe, Western Europe, and the Rest of Europe. In 2014, Western Europe emerged as the dominant market for molecular diagnostic across Europe with 47.1% share. The increasing prevalence of infectious diseases has propelled the demand for molecular diagnostic tests in this region. In addition to this, the cost efficiency of molecular diagnostic tests is likely to drive the growth of this regional market over the forecast period.
The research report further states that analysts project Eastern Europe to exhibit attractive opportunities for molecular diagnostic in Europe. It is expected to rise at the highest growth rate during the forecast period. The increasing disposable income of people and the growing awareness among them regarding healthcare is anticipated to boost the demand for molecular diagnostic tests in Eastern Europe in the coming years.
Molecular diagnostics finds widespread application in blood screening, microbiology, infectious disease testing, oncology, genomics, prenatal and newborn screening, and women's health monitoring, states the report.
View exclusive Global strategic Business report : http://www.transparencymarketresearch.com/europe-molecular-diagnostics-market.html
The report also presents a competitive analysis of the molecular diagnostics market in Europe. According to it, Roche Holding AG led this market in 2014 and was closely followed by Abbott Laboratories. The wide range of products offered by Roche has been significantly aiding its exponential growth.
Other prominent market players mentioned in this research study are Bio-Rad Laboratories Inc., QIAGEN N.V., Siemens AG, Thermo Fisher Scientific Inc., Meridian Bioscience Inc., bioMérieux SA, Alere Inc., Affymetrix Inc., Cepheid Inc., Agilent Technologies Inc., Danaher Corp., Hologic Inc., PerkinElmer Inc., and Randox Laboratories Ltd.
Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.
Transparency Market Research
90 State Street,
NY - 12207
USA - Canada Toll Free 866-552-3453
For more information:
Last updated on: 18/10/2016
PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.